We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Multipurpose Biosensors Rely on Luciferase to Light up Target Molecules

By LabMedica International staff writers
Posted on 05 Aug 2015
A team of Swiss molecular biologists developed a luminescent marker system that sends out a light signal after binding to a specific target molecule.

Investigators at Ecole Polytechnique Fédérale de Lausanne (Switzerland) attached a small chemical tag to the enzyme luciferase, which catalyzes the light produced by fireflies. More...
The tag molecule prevented luciferase from producing light, but when the tag detected its target protein, it released luciferase and attached to that protein instead. As a result, luciferase was free to emit a light, which was the signal that the target molecule had been found.

As proof-of-principle the investigators described in the July 22, 2015, online edition of the journal Nature Communications a luciferase controlled by human carbonic anhydrase whose activity could be controlled by proteins or small molecules in vitro and on living cells, and novel fluorescent and bioluminescent biosensors.

"You can think of the tagged luciferase as a cyborg molecule," said senior author Dr. Kai Johnsson, professor of chemistry at Ecole Polytechnique Fédérale de Lausanne. "Half bio, half synthetic. How could you make luciferase sensitive to the presence of another protein just through mutations? It is a lot of work. With this chemical trick, all we have to worry about is designing an appropriate tag that can recognize the target protein. This is a generalized design. It shows how you can exploit synthetic chemistry to create sophisticated biosensor proteins."

Related Links:
Ecole Polytechnique Fédérale de Lausanne



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Drug Test Kit
DrugCheck 3000
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The new study aims to enhance colorectal cancer prevention by identifying polyp molecular signals (Photo courtesy of Shutterstock)

RNA Screening Test Could Detect Colon Polyps Before They Become Cancerous

Colorectal cancer has become a growing health crisis, especially as it increasingly affects younger adults in their 20s, 30s, and 40s, while screening rates remain low. Colorectal cancer is now the leading... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: The new method identifies tissue phenotypes defined by spatial transcriptomics to over 89% accuracy using label-free microscopy images alone (Photo courtesy of T. Sawyer/University of Arizona, S. Guan et al.)

New AI-Based Method Effectively Identifies Disease Phenotypes Using Light-Based Imaging

Precision medicine, where treatment strategies are tailored to a patient's unique disease characteristics, holds great promise for cancer therapy. However, identifying disease phenotypes, which are critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.